The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients : Transplantation

Journal Logo

Original Clinical Science—General

The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients

Lim, Jeong-Hoon MD, PhD1; Kwon, Soie MD, MS2; Jeon, Yena MS3; Kim, Young Hoon MD, PhD4; Kwon, Hyunwook MD, PhD4; Kim, Yon Su MD, PhD2; Lee, Hajeong MD, PhD2; Kim, Yong-Lim MD, PhD1; Kim, Chan-Duck MD, PhD1; Park, Sun-Hee MD, PhD1; Lee, Jong Soo MD, PhD5; Yoo, Kyung Don MD, PhD5; Son, Hyung Eun MD, MS6; Jeong, Jong Cheol MD, PhD6; Lee, Jeonghwan MD, PhD7; Lee, Jung Pyo MD, PhD7; Cho, Jang-Hee MD, PhD1

Author Information
Transplantation 106(9):p e404-e412, September 2022. | DOI: 10.1097/TP.0000000000004228
  • Buy
  • SDC
  • Infographic

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid